Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients

NCT06908473 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

530

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome
Cardiovascular Disease (CKD)
Cerebrovascular Disease
Qi Deficiency and Blood Stasis

Interventions

DRUG: Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment.
DRUG: A placebo capsule that is identical in appearance, size, color, formulation, weight, taste, and smell to TJC

Sponsor

Guangdong Provincial Hospital of Traditional Chinese Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]